The value of quantitative patient preferences in regulatory benefit-risk assessment

Mart Oude Egbrink, Maarten Joost IJzerman

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Quantitative patient preferences are a method to involve patients in regulatory benefit-risk assessment. Assuming preferences can be elicited, there might be multiple advantages to their use. Legal, methodological and procedural issues do however imply that preferences are currently at most part of the solution on how to best involve patients in regulatory decision making. Progress is recently made on these issues.
Original languageEnglish
Article number22761
Pages (from-to)-
JournalJournal of market access & health policy
Volume2
Issue number22761
DOIs
Publication statusPublished - 2014

Keywords

  • IR-90447
  • METIS-303311

Fingerprint Dive into the research topics of 'The value of quantitative patient preferences in regulatory benefit-risk assessment'. Together they form a unique fingerprint.

  • Cite this